Table 1 Summary of the follow-up visit schedule and assessed parameters at each time point. (CEA, carcinoembryonic antigen; MRI, Magnetic Resonance Imaging; CT, computed tomography; QoL, Quality of life)
ETAP follow-up schedule | Inclusion | Surgery | 3 months | 6 months | 12 months | 24 months | 36 months |
|---|---|---|---|---|---|---|---|
Clinical evaluation | X | X | X | X | X | X | X |
Surgical complications | X | X | |||||
CEA | X | X | X | X | X | X | |
Endorectal utrasound | X | X | |||||
Rectal MRI | X | X | |||||
CT thorax/abdomen or TEP-FDG | X | X | X | X | X | ||
QoL | X | X | X | X | X | X |